{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:57:47Z","timestamp":1781557067298,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jns.2024.123359","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:30:25Z","timestamp":1734568225000},"page":"123359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Diagnostic value of extracellular matrix degradation biomarkers in serum from patients with Parkinson's disease"],"prefix":"10.1016","volume":"468","author":[{"given":"Signe","family":"Holm Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.123359_bb0005","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JPD-202346","article-title":"People with Parkinson\u2019s disease: what symptoms do they Most want to improve and how does this change with disease duration?","volume":"11","author":"Port","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jns.2024.123359_bb0010","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.jns.2024.123359_bb0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ejn.14094","article-title":"The clinical heterogeneity of Parkinson\u2019s disease and its therapeutic implications","volume":"49","author":"Greenland","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jns.2024.123359_bb0020","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jns.2024.123359_bb0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2125.2012.04192.x","article-title":"Progression of motor and nonmotor features of Parkinson\u2019s disease and their response to treatment","volume":"74","author":"Vu","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2024.123359_bb0030","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp-2018-318337","article-title":"Developing and validating Parkinson\u2019s disease subtypes and their motor and cognitive progression","volume":"89","author":"Lawton","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2024.123359_bb0035","doi-asserted-by":"crossref","first-page":"1022754","DOI":"10.3389\/fncel.2022.1022754","article-title":"A glial perspective on the extracellular matrix and perineuronal net remodeling in the central nervous system","volume":"16","author":"Tewari","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"76","key":"10.1016\/j.jns.2024.123359_bb0040","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s00018-019-03182-6","article-title":"Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights","volume":"7616","author":"Krishnaswamy","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jns.2024.123359_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuroscience.2012.05.034","article-title":"Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment","volume":"217","author":"Howell","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2024.123359_bb0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.matbio.2018.01.015","article-title":"Role of proteoglycans in neuro-inflammation and central nervous system fibrosis","volume":"68\u201369","author":"Heindryckx","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jns.2024.123359_bb0055","series-title":"A glycomics and proteomics study of aging and parkinson\u2019s disease in human brain","first-page":"12804","volume":"10","author":"Raghunathan","year":"2020"},{"key":"10.1016\/j.jns.2024.123359_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087435","article-title":"Proteins and transcriptional dysregulation of the brain extracellular matrix in Parkinson\u2019s disease: a systematic review","volume":"24","author":"Rike","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2024.123359_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuro.2019.02.020","article-title":"In silico method for identification of novel copper and iron metabolism proteins in various neurodegenerative disorders","volume":"73","author":"Kumar","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jns.2024.123359_bb0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12031-018-1151-x","article-title":"Biglycan, a nitric oxide-downregulated proteoglycan, prevents nitric oxide-induced neuronal cell apoptosis via targeting Erk1\/2 and p38 signaling pathways","volume":"66","author":"Chen","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jns.2024.123359_bb0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.14802\/jmd.09017","article-title":"Usefulness of diffusion-weighted MRI for differentiation between Parkinson\u2019s disease and Parkinson variant of multiple system atrophy","volume":"2","author":"Chung","year":"2009","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.jns.2024.123359_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fnagi.2018.00109","article-title":"Cellular and molecular basis of neurodegeneration in Parkinson disease","volume":"10","author":"Zeng","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2024.123359_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms231911085","article-title":"The role of extracellular matrix in human neurodegenerative diseases","volume":"23","author":"Pint\u00e9r","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2024.123359_bb0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1152\/jn.00363.2023","article-title":"Body mass index in patients with Parkinson\u2019s disease: a systematic review","volume":"131","author":"Li","year":"2024","journal-title":"J. Neurophysiol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24004957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24004957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T01:58:57Z","timestamp":1736474337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24004957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":18,"alternative-id":["S0022510X24004957"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123359","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic value of extracellular matrix degradation biomarkers in serum from patients with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123359"}}